Redhill Biopharma
RDHL
₹128.88
Share price
-9.20%
Change (1 day)
-84.34%
Change (1 year)
Categories
EPS for Redhill Biopharma (RDHL)
EPS in 2023 (TTM): -₹53,915
According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -₹60,956. In 2017 the company made an earnings per share (EPS) of -₹2,17,700 a decrease over its 2016 EPS that were of -₹1,91,576.
EPS history for Redhill Biopharma from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -₹53,915 | |
| 2017 | -₹2,17,700 | 13.64% |
| 2016 | -₹1,91,576 | 9.12% |
| 2015 | -₹1,75,561 | 68.01% |
| 2014 | -₹1,04,496 | -25.93% |
| 2013 | -₹1,41,070 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | ₹247.93 | -100.41% | 🇫🇷 France |
 Merck MRK | ₹600.62 | -100.99% | 🇺🇸 USA |
 GlaxoSmithKline GSK | ₹135.83 | -100.22% | 🇬🇧 UK |
 Taro Pharmaceutical TARO | ₹106.24 | -100.17% | 🇮🇱 Israel |
 Teva Pharmaceutical Industries TEVA | -₹99.27 | -99.84% | 🇮🇱 Israel |